Hutch News

Hutch News

Stories tagged 'Seattle Cancer Care Alliance'

'Pinktober': What Breast Cancer Awareness Month means to patients, care providers and others

Some see it as invaluable for education and advocacy while others, including male breast cancer patients, may feel left out

Oct. 12, 2017 | By Diane Mapes / Fred Hutch News Service

Breast Cancer Awareness Month definitely means different things to different people. For some, it’s about celebrating strength and survival. For others, it's about advocacy and a push to educate people about the realities of the disease. Read on for a few thoughts about BCAM from breast cancer patients, researchers and caregivers.

View story >


At Obliteride, finding strength amid the fear of cancer

Childhood cancer survivor turned oncology nurse rides to raise money for research

Aug. 7, 2017 | By Susan Keown / Fred Hutch News Service

Childhood cancer survivor Katie Bunker, now a pediatric oncology nurse at Seattle Children's Hospital, will be participating this weekend in her second Obliteride, riding 50 miles as a member of Team Baldy Tops.

View story >


Love in the time of cancer

Getting dumped after diagnosis isn’t the only story out there; meet three couples who found romance despite disease

Feb. 14, 2017 | By Diane Mapes / Fred Hutch News Service

Getting dumped after diagnosis isn’t the only plotline when it comes to love and cancer. Fred Hutch News Service talked to three couples who found romance despite disease. This Valentine's Day, we share their stories.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 22, 2016

For fourth year in a row, Fred Hutch/SCCA transplant rates among best in the U.S.; immuntherapy symposium available on video for those who couldn't attend the event

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 8, 2016

Good News: $475K gift fuels expansion of antibody technology; Dr. Hansen honored for BMT work; Senate passes 21st Century Cures Act, sends to Obama

View story >


Immunotherapy shows promise in preventing leukemia relapse

Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission after more than two years

Dec. 5, 2016 | By Susan Keown / Fred Hutch News Service

For patients with high-risk acute myeloid leukemia, relapse after bone marrow transplant signals a low chance of survival. But results from a small trial of genetically engineered immune cells show promise for keeping these patients out of danger: Of the 12 AML patients who received this experimental T-cell therapy after a transplant put their disease in remission, all are still in remission after a median follow-up of more than two years.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.